Clinical trial
A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.
NCT00157963 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.
- Lead sponsor
- Organon and Co
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 5, 2005
- Completion date
- February 8, 2006
- Enrollment
- 174 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.